These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31562050)

  • 1. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans.
    Soohoo M; Moradi H; Obi Y; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Clin Lipidol; 2019; 13(5):744-753.e15. PubMed ID: 31562050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans.
    Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Am Heart Assoc; 2021 Dec; 10(23):e022988. PubMed ID: 34729994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.
    Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Nephron; 2022; 146(5):457-468. PubMed ID: 35354153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglycerides and Renal Outcomes According to Albuminuria and in Consideration of Other Metabolic Syndrome Components in Diabetic US Veterans.
    Rizk JG; Hsiung JT; Arif Y; Hashemi L; Sumida K; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2023; 54(1-2):14-24. PubMed ID: 36889289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
    Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.
    Navaneethan SD; Schold JD; Arrigain S; Thomas G; Jolly SE; Poggio ED; Schreiber MJ; Sarnak MJ; Nally JV
    Nephrol Dial Transplant; 2012 Aug; 27(8):3228-34. PubMed ID: 22553369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.
    Bowe B; Xie Y; Xian H; Balasubramanian S; Zayed MA; Al-Aly Z
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1784-1793. PubMed ID: 27515591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
    Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression.
    Novak M; Mucsi I; Rhee CM; Streja E; Lu JL; Kalantar-Zadeh K; Molnar MZ; Kovesdy CP
    Diabetes Care; 2016 Nov; 39(11):1940-1947. PubMed ID: 27311494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Sumida K; Molnar MZ; Potukuchi PK; Thomas F; Lu JL; Obi Y; Rhee CM; Streja E; Yamagata K; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2018 Feb; 33(2):264-273. PubMed ID: 28064159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
    Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
    Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Hypertriglyceridemia With the Incidence and Progression of Chronic Kidney Disease and Modification of the Association by Daily Alcohol Consumption.
    Tsuruya K; Yoshida H; Nagata M; Kitazono T; Iseki K; Iseki C; Fujimoto S; Konta T; Moriyama T; Yamagata K; Narita I; Kimura K; Kondo M; Asahi K; Ohashi Y; Watanabe T
    J Ren Nutr; 2017 Nov; 27(6):381-394. PubMed ID: 28668283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum magnesium, mortality and disease progression in chronic kidney disease.
    Azem R; Daou R; Bassil E; Anvari EM; Taliercio JJ; Arrigain S; Schold JD; Vachharajani T; Nally J; Na Khoul GN
    BMC Nephrol; 2020 Feb; 21(1):49. PubMed ID: 32050924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum testosterone levels and mortality in men with CKD stages 3-4.
    Khurana KK; Navaneethan SD; Arrigain S; Schold JD; Nally JV; Shoskes DA
    Am J Kidney Dis; 2014 Sep; 64(3):367-74. PubMed ID: 24726629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.